Anika Therapeutics, Inc. Construction Payable, Current
Anika Therapeutics, Inc. (ANIK) had Construction Payable, Current of $804.00 thousand as of 2016-12-31, per its 10-K filed 2018-02-27.
Discontinued › Notes › Accounts Payable and Accrued Liabilities, Current
us-gaap:ConstructionPayableCurrent · last filed 2018-02-27
- 2016-12-31: Construction Payable, Current $804.00K.
- 2016-09-30: Construction Payable, Current $336.00K.
- 2016-06-30: Construction Payable, Current $1.77M.
- 2016-03-31: Construction Payable, Current $2.07M.
| Period end | Construction Payable, Current | Construction Payable, Current as first filed |
|---|---|---|
| 2016-12-31 | $804.00K 10-K · filed 2018-02-27 | |
| 2016-09-30 | $336.00K 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $1.77M 10-Q · filed 2016-08-01 | |
| 2016-03-31 | $2.07M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $804.00K 10-Q · filed 2017-05-04 | $415.00K 10-K · filed 2016-03-10 |
| 2015-09-30 | $2.07M 10-Q · filed 2015-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |